RespireRx Pharmaceuticals Inc (RSPI)

[fly_fisherman]

Essentially

ResolutionRx(R&D focus only) and RespireRx have the same CEO and management.

First off, I am no expert with these types of transactions. The way I take this they were doing this specific for the sleep apnea drug to establish valuation and for funding the completion of the project. There were specific benefits etc. in Australia in the form of tax incentives etc. ResolutionRx Ltd (Australian Company Number a/k/a ACN 664 925 651) was formed in Australia on 11th January 2023 by RespireRx as an unlisted public company. The company was formed by RespireRX.

What I liked was: "which assumes 90% of a US$25 million maximum value for the net assets provided by RespireRx to ResolutionRx and is subject to adjustment downward, but not upward, based upon the result of the independent valuation." This is the value given TODAY. There is much more to this POSITIVE than meets the eye folks imho!

They placed a 25-million-dollar maximum value for essentially the IP/patent for the (sleep apnea drug alone). Easily why we see this as a vastly undervalued stock with a market cap in the 900,000 range for all the drugs.

Again, I am no expert, but I also see how $RSPI has been trading. Something POSITIVE and potentially BIG is coming imho.